Urinary Tract Infections (UTIs) account for 8.3 million doctor visits, 1 million emergency department (ED) visits, and 100,000 hospitalizations annually, with an estimated cost of $1 billion annually in the U.S.

The Problem:

The spread of fluoroquinolone resistant E. coli, extended spectrum beta-lactamase (ESBL), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE), among other emerging bacterial resistance factors contributes to increasing treatment cost and poor patient outcomes.

A New Tool in the Fight Against Antibiotic Resistance:

MicroPathID – Urine Pathogen Panel (UPP)Uses real-time PCR to identify and quantify 17 pathogenic bacteria and fungal species associated with infections of the urinary tract and detects up to 36 genes that confer antibiotic resistance across 10 drug classes.  Confirmatory urine culture and susceptibility results are also provided to help guide antibiotic selection and assist with antimicrobial stewardship.

Rapid PCR Detection
17 Pathogenic Bacteria
and Fungal Species

Acinetobacter baumannii
Citrobacter freundii
Enterobacter aerogenes
Enterobacter cloacae
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella oxytoca
Klebsiella pneumoniae
Morganella morganii
Proteus mirabilis
Proteus vulgaris
Staphylococcus aureus
Pseudomonas aeruginosa
Staphylococcus saprophyticus
Streptococcus agalactiae
Candida albicans

Rapid PCR Detection
36 Gene Antibiotic
Resistance Panel
~10 Drug Classes

AmpC beta lactamase
Extended Spectrum Betalactamase
Macrolides, lincosamides, streptogramins

Confirmatory Culture
and Susceptibility

Antibiotic Susceptibility 

Sexually Transmitted Infection Panel

MicroPathID-UPP Panel also offers tests for the 4 common STI pathogens, including Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium.

Clinical Advantages:  MicroPathID – UPP Panel

  • Rapid PCR results on pathogen identification and antibiotic resistance
    • 12 – 24 hours from specimen receipt
  • Improved Sensitivity
    • 3-5X more sensitive than conventional culture
  • Can detect polymicrobial infections
  • Unaffected by concurrent antibiotic use
  • Culture confirmation and susceptibility
    • Phenotypic characterization combined with genotypic information for improved outcomes

The Process

The Urine Pathogen Panel is performed by Bostwick Laboratories from a clean catch urine specimen.

Day 1
Collect clean catch urine sample

Day 2
Specimen arrives at Bostwick Laboratories – PCR testing and cultures begin

Day 2-3
Receive PCR results of 17 pathogens and Antibiotic Resistance Genes

Day 4
Receive confirmatory culture and susceptibility results

Day 4
Informed antibiotic selection

1 Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med.2002;113(suppl 1A):5S-13S.

For more information about Bostwick Laboratories click the logo below to visit their full site.